With this pathology, the clinical signs of AD can be augmented by assessing abnormalities in brain volume and quantifying tau and Aβ levels in the cerebrospinal fluid (CSF) for dementia diagnosis. The gene discussed is MAPT; the disease is Alzheimer disease.